Bladder Cancer News and Research

Latest Bladder Cancer News and Research

First human recipients of laboratory-grown organs

The first human recipients of laboratory-grown organs were by Anthony Atala, M.D., director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine. In The Lancet, Atala describes long-term success in children and teenagers who received bladders grown from their own cells.

4 Apr 2006

Delaying urgery decreases survival for bladder cancer patients

Bladder cancer patients whose surgery was delayed for more than three months after their diagnosis were more likely to die from their disease than patients whose surgery was performed sooner, according to a study by researchers at the University of Michigan Comprehensive Cancer Center.

4 Apr 2006

Serum tumor markers predict extravesical disease in clinical stage T2 bladder cancer

Bladder cancer clinical staging is notoriously poor in patients with muscle invasive disease.

31 Mar 2006

Anti-cancer drugs based on platinum

Researchers at Virginia Commonwealth University's Massey Cancer Center have created a new platinum-based, anti-cancer agent able to overcome acquired drug resistance by first modifying the way it is absorbed into cancer cells and then attacking the DNA of those cancer cells.

6 Jan 2006

HRAS mutation analysis in Costello Syndrome

Gene mutations in the HRAS sequence are present in most patients affected with Costello syndrome, according to a new study in the American Journal of Medical Genetics. The mutations occurred de novo in patients, meaning, they were not observed in their parents' genes.

5 Dec 2005

Simple urine test detects bladder cancer

According to Italian researchers a simple and accurate urine test can detect bladder cancer early and they say the test should be used on smokers and others prone to the disease.

26 Oct 2005

Measurement of telomerase activity in urine appears useful for detection of bladder cancer in men

The incidence of human bladder cancer has greatly increased over the last few decades, with more than 60,000 new cases diagnosed each year in the United States alone, and now represents the 4th most common malignancy in men and the 10th most common in women, according to background information in the article.

25 Oct 2005

No evidence of a "safe" threshold with environmental toxins

Four of the most widespread environmental toxins - lead, trihalomethanes (found in drinking water), ionizing radiation from indoor radon gas, and tobacco smoke - can cause serious damage to health even at very low levels, say researchers in the open access journal PLoS Medicine.

18 Oct 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Pregnancy fears on drinking water byproducts may be overstated

Fears that chemical byproducts resulting from purifying drinking water with chlorine boost the chances that pregnant women will miscarry were not supported by the results of a major new study. If such threats exist at all, which is uncertain, they likely are modest, it concludes.

1 Aug 2005

Broccoli may help prevent bladder cancer

Researchers have isolated compounds from the vegetable broccoli that they believe may help prevent or slow the progress of bladder cancer.

28 Jul 2005

Clear survival benefit for patients who have high-risk cancer surgeries at hospitals that commonly perform the procedures

Choosing a hospital that either performs many cystectomies--the surgical removal of the urinary bladder - or has a high nurse-to-patient ratio minimizes post-operative complications after the procedure, according to a new study.

25 Jul 2005

British men refuse to recognise they are fat

A new survey by Cancer Research UK, released to launch their Man Alive Campaign, is suggesting that 25% of British men are "in denial" about their waist measurement, and most men, when questioned were unaware that being overweight, obese, or inactive, increases the risk of cancer.

4 Jul 2005

Bioniche Life Sciences granted European patent

Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)

30 May 2005

No link found between hair dyes and cancers

The growing worldwide concern about a possible link between hair dyes and some forms of cancer, which was further fuelled by one recent study showing an apparent positive relationship, prompted a European Commission safety panel to call for an urgent review.

24 May 2005

Herceptin could be used safely for bladder cancer

A targeted drug shown to improve the outcome of certain breast cancer patients may be of use in the treatment of advanced cases of bladder cancer, according to new research led by the University of Michigan Comprehensive Cancer Center.

15 May 2005

Men who are treated for prostate cancer with radiation may have almost doubled their risk of developing rectal cancer

A study in the American Gastroenterological Association (AGA) journal Gastroenterology has found that men who are treated for prostate cancer with radiation may have almost doubled their risk of developing rectal cancer when compared to men who opted to have surgery.

4 Apr 2005

Radiation for prostate cancer doubles the risk of developing rectal cancer

Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.

3 Apr 2005

Bioniche receives European patent

Bioniche Life Sciences Inc., a research-based, technology-driven human and animal health biopharmaceutical company, today announced that it has had an additional European patent granted by the European Patent Office (EPO) on its core mycobacterial cell wall technology.

29 Mar 2005

More dependable, less expensive tool to help detect bladder cancer earlier

Researchers at The University of Texas M. D. Anderson Cancer Center found that a simple test that can be administered and read in the doctor's office was three times more effective than a conventional laboratory test for detecting bladder cancer.

15 Feb 2005